Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Intervention and Therapeutics
Metadata
Title
Drug-eluting stent thrombosis: current and future perspectives
Publication date
01-04-2021
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2021
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-021-00754-x

Other articles of this Issue 2/2021

Cardiovascular Intervention and Therapeutics 2/2021 Go to the issue

Original Article

Percutaneous closure of residual atrial septal defect after surgical closure

Invited Review Article

Practical utilization of cardiac computed tomography for the success in complex coronary intervention

Invited Review Article

A contemporary review of clinical significances of percutaneous coronary intervention for chronic total occlusions, with some Japanese insights

Invited Review Article

Optical coherence tomography-guided percutaneous coronary intervention: a review of current clinical applications

Images in Cardiovascular Intervention

Transcatheter mitral valve repair with MitraClip in a patient on hemodialysis with huge flail gap

Original Article

One-year limb outcome and mortality in patients undergoing revascularization therapy for acute limb ischemia: short-term results of the Edo registry

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits